HBCM
ABBV icon

Heron Bay Capital Management’s AbbVie ABBV Stock Holding History

Heron Bay Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,018
Closed -$2.03M – 69
2021
Q4 		$2.03M Buy
15,018
+292
+2% +$34.5K 1% 41
2021
Q3 		$1.59M Buy
14,726
+2,299
+19% +$263K 0.82% 42
2021
Q2 		$1.4M Sell
12,427
-405
-3% -$45.6K 0.77% 45
2021
Q1 		$1.39M Buy
12,832
+2,552
+25% +$273K 0.83% 44
2020
Q4 		$1.1M Buy
+10,280
New +$988K 0.72% 46

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Heron Bay Capital Management's ABBV Position: Q1 2022 in Review

Heron Bay Capital Management sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 15,018 shares — an estimated $2.03M sold.

Heron Bay Capital Management first reported a position in ABBV in Q4 2020 and held it in 5 quarters. The position peaked at $2.03M in Q4 2021. 3,053 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

  • Heron Bay Capital Management reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
  • Heron Bay Capital Management sold 15,018 AbbVie shares in Q1 2022, an estimated $2.03M.
  • Heron Bay Capital Management first reported a position in AbbVie in Q4 2020 and held it in 5 quarters.
  • Heron Bay Capital Management's AbbVie position peaked at $2.03M in Q4 2021.
  • 3,053 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Heron Bay Capital Management's 13F filing for Q1 2022, filed 16 May 2022.